Covista Says Employer Students Cost Less to Win. It Won't Say How Many It Has.

Part of the EFFA Tuition Benefits Brain Trust: Market Intelligence. Last verified November 4, 2026. Sources are listed at the end.

What Covista's Q1 fiscal 2027 results and call say about employer-funded enrollment, health-system pipelines and what students cost to acquire.

How to read the numbers. Reported = Covista's own figure. Derived = our arithmetic on reported figures, formula shown. Estimated = our model, assumptions stated.

The short version

Covista (formerly Adtalem) told investors that "a significant portion" of its students now arrive through employers who help pay, and that health-system partnerships bring "more durable enrollment at a lower cost of acquisition." It is one of the clearest claims about employer-channel economics from any operator this season. It came with no numbers: no employer share, no cost per start, no partner count. And none of the analysts on the call asked. Unlike Phoenix, where employer students pull revenue per student down, Covista's revenue per student rose 2.9%, which suggests its employer deals are not being bought with deep discounts.

Results in one paragraph (reported)

Revenue for the quarter ended Sep 30, 2026 was $511.5M, up 10.7%. Total enrollment was 104,713, up 7.6%, the 13th straight quarter of growth. Walden grew enrollment 12.8% to 58,881; Chamberlain grew 1.3% to 40,351; Medical and Veterinary grew 3.5% to 5,481. FY2027 revenue guidance was raised to $2.06B to $2.095B. [Release, Oct 29, 2026]

1. Employer-funded enrollment

Share (reported, qualitative only): "a significant portion of our students now arrive through employers who help pay for their education." (CEO Steve Beard) [Call]
Share (not disclosed): Covista does not report what portion. Strategic Education (34.7%, Q2 2026) and Phoenix (36%, Q4 FY2026) do.
Health-system pipelines (reported):
SSM Health (via Chamberlain, since July 2025) "has outperformed, and we have raised enrollment targets with them." [Call]
Advocate Health (since June 2026) is expanding to all three Chicago-area Chamberlain campuses. [Call; release]
Who pays the tuition, and how much, is not disclosed for either deal.
Where the growth came from (derived): Walden added 6,665 students, about 91% of Covista's total growth of 7,354. Chamberlain added 505. [Release]
Strategy (reported): "employer integration" is one of four pillars of the company's plan, and its fiscal 2029 targets cite growth "through new programs, geographies, brands and employer integration." [Release; Investor Day]

2. What students cost to acquire: B2C vs B2B

The claim (reported): health systems "get a differentiated and proprietary pipeline. We get more durable enrollment at a lower cost of acquisition." (CEO) [Call]
The numbers behind the claim: not disclosed. Covista does not report marketing expense, cost per start, or employer-channel costs separately.
What we can see (derived): student services and administrative expense, which includes marketing, was $192.6M, 37.6% of revenue vs 38.0% a year earlier. Per student it rose about 1.9%, to roughly $1,840 per quarter. The CFO said operating leverage from growth "more than offset continued investments in marketing." [Release; call]
AI search (reported): Covista says the shift to AI search has "not really resulted in any real headwinds from an inquiry, application, or new enrollment perspective," and that it has not had to raise paid search spending the way some competitors have. [Call]
Our read: Covista is the counter-example to Phoenix. Phoenix's consumer channel was hit by AI search and its employer channel carried the growth. Covista says its consumer channel is fine and its employer channel is cheaper. If both are true, the employer channel is a margin play for Covista, not a rescue.

3. Price and revenue per student

Revenue per student, quarter (derived):
Chamberlain: $192.4M ÷ 40,351 ≈ $4,770 vs $4,500, up 6.0%.
Walden: $216.7M ÷ 58,881 ≈ $3,680 vs $3,640, up 1.2%.
Medical and Veterinary: ≈ $18,690 vs $17,580, up 6.3%.
Total: ≈ $4,885 vs $4,750, up 2.9%.
Why (reported): "better mix, more credit hours per student, and pricing." Discounts and scholarships were not discussed. [Call]
Contrast with Phoenix: Phoenix said employer discounts were the biggest reason its revenue per student fell. Covista's revenue per student rose. Either Covista's employer students pay close to full price, or they are too small a share to move the average. Covista's disclosures don't tell us which.
A pricing cut is coming in one place (reported): Chamberlain's RN-to-BSN program, which serves working nurses, a group often supported by employer tuition benefits, was soft; management plans to "position that product more competitively from a pricing perspective." [Call]

4. Lifetime value

Durability claim (reported): employer pipelines produce "more durable enrollment." No persistence data by channel. [Call]
A miss on persistence (reported): fewer Chamberlain continuing students returned in September than forecast; management expects to fix it "with some additional persistence efforts." [Call]
Walden (reported): "really, really strong persistence." [Call]
Our read: "durable" is the right claim for the employer channel: a nurse whose tuition is tied to a job at SSM or Advocate has a reason to finish. But no operator has yet published employer-vs-consumer persistence. Whoever does will set the benchmark.

5. How durable each channel is

B2C: stable so far through the AI-search shift, by Covista's account, helped by favorable descriptions of its schools in AI answers ("about 90% positive"). [Call]
B2B: built on multi-year health-system commitments with clinical placements and job guarantees, which are harder to replicate than a benefits-menu listing.
Federal loan changes (reported): some students started early "ahead of changes to federal loan programs," mainly in medical and veterinary. Management does "not expect the loan changes to affect long term demand." [Call]

6. How Covista sells to employers

The model (reported): deep, bespoke partnerships with large health systems: tuition support, clinical training in the system's facilities, a job on graduation and a work commitment. Advocate adds student-loan support while the nurse works there. [Call; partner announcements]
Sales structure, partner count, and cost: not disclosed.
Our read: this is the opposite of Phoenix's model. Phoenix has 2,500 employers on its list and manages 600. Covista highlights two marquee health systems. Large-system deals are durable but slow to sign, and most hospitals can't build a custom program. The mid-size health system is the unserved market.

7. Policy exposure

Federal loan limits (reported): the call focused on graduate and professional loan changes, especially for medical school and the question of whether nursing counts as graduate or professional for loan limits. [Call, BMO question]
Our read: Walden's graduate nursing and health programs and Covista's medical schools rely on federal graduate borrowing. Where new loan limits leave a gap, employer tuition support and loan repayment (as in the Advocate deal) are among the few ways to fill it.
Section 127, Workforce Pell, 90/10: not mentioned. The 2027 inflation-indexed Section 127 limit and permanent tax-free student-loan repayment fit Covista's health-system model exactly, and management did not bring them up.

8. What analysts asked

Four analysts asked nine questions on loan limits, Chamberlain's slower growth, margins, revenue per student, AI search, Walden's outlook and receivables.
None asked about the employer channel, despite the CEO's claim that it brings lower acquisition costs. Investors are not yet pricing the employer channel at Covista.

9. Management language

"A significant portion of our students now arrive through employers who help pay for their education." (CEO)
"We get more durable enrollment at a lower cost of acquisition." (CEO)
"Our partnership with SSM Health has outperformed, and we have raised enrollment targets with them." (CEO)
On AI search: "this is a real dynamic for any company that serves consumers." (CEO)

We will check in January whether "significant portion" becomes a number.

What they didn't say

What share of students are employer-funded, or how many employer partners Covista has.
Cost of acquisition for employer vs consumer students, despite claiming one is lower.
Who pays tuition, and how much, in the SSM and Advocate deals.
Persistence for employer-funded students.
Anything on Section 127 or Workforce Pell.

So what

For employers, especially health systems: a school group that says it graduates more healthcare students than any other U.S. institution says your employees are its cheapest, most durable students. That is leverage. Ask what the school saves on acquisition, and ask for it back as price, clinical capacity or reporting.
For schools: Covista's two health-system deals show what a deep partnership looks like, but they are expensive to build one at a time. The volume is in the hundreds of mid-size systems that need a simpler way to fund nurses.
For direct-bill funding: if employer students really are cheaper to acquire and stay longer, the friction left is payment. Paying the school directly, so nurses never front tuition, makes the "durable enrollment" claim easier to deliver.

EFFA lets employers pay schools directly for their employees' education. Request a demo.